Our evolving understanding of monogenic diabetes: Possibilities of improving glycaemic control following transfer from insulin to sulphonylureas

References 

1. Shepherd M. Recognising maturity onset diabetes of the young. Journal of Diabetes Nursing. 2001;5–6:168–172
2. Hattersley AT. Molecular genetics goes to the diabetes clinic. Clinical Medicine. 2005;5–5:476–481
3. Shepherd M, Hattersley AT. ‘I don’t feel like a diabetic anymore’: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clinical Medicine. 2004;4:144–147
4. Hattersley AT, Bruining J, Shield J, Njolstad P, Donaghue K. ISPAD clinical practice consensus guidelines 2006–2007. The diagnosis and management of monogenic diabetes in children. Pediatric Diabetes. 2006;7:352–360
   • MEDLINE
5. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabetic Medicine. 1998;15:539–553
6. R. Murphy, S. Ellard, A.T. Hattersley, Clinical implications of a molecular genetic classification of monogenic beta cell diabetes, Nature clinical practice endocrinology and metabolism, 2008, Feb 26 [Epub ahead of print].
7. Frayling TM, Bulman MP, Ellard S, et al. Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity onset diabetes of the young in the UK. Diabetes. 1997;46, 4:720–725
8. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 2003;362:1275–1281
   • Abstract
   • Full Text
   • Full-Text PDF (155 KB)
9. Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, et al. Macrosomia and hyperinsulinaemic hypoglycaemis in patients with heterozygous mutations in the HNF4A gene. PLoS Medicine. 2007;4:e118
10. Bingham C, Hattersley AT. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1 beta. Nephrology Dialysis Transplantation. 2004;19:2703–2708
11. Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C, et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1 alpha and -1beta mutations. Diabetes Care. 2004;27:1102–1107
    • MEDLINE
12. Stride A, Vaxillaire M, Tuomi T, Barbetti F, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia. 2002;45:427–435
    • MEDLINE
13. Velho G, Blanche H, Vaxillaire M, et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia. 1997;40:217–224
    • MEDLINE
14. Spyer G, Hattersley AT, Sykes JE, Sturley RH, MacLeod KM. Influence of maternal and fetal glucokinase mutations in gestational diabetes. American Journal of Obstetrics and Gynaecology. 2001;185(1):240–241
    • Abstract
    • Full Text
    • Full-Text PDF (57 KB)
15. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics. 1998;19:268–270
    • MEDLINE
16. Iafusco D, Stazi MA, Cotichini R, et al. Permanent diabetes mellitus in the first year of life. Diabetologia. 2002;45:798–804
    • MEDLINE
17. Edghill EL, Dix RJ, Flanagan SE, Bingley PJ, Hattersley AT, Ellard S, et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes. 2006;55:1895–1898
    • MEDLINE
18. E.L. Edghill, S.E. Flanagan, A.M. Patch, C. Boustred, A. Parrish, B. Shields, M. Shepherd et al., Insulin mutation screening in 1044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood, Diabetes 57, 2008, April [Epub ahead of print].
19. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes; new clinical syndromes, new scientific insights and new therapy. Diabetes. 2005;54:2503–2513
    • MEDLINE
20. Pearson ER, Flechtner I, Njolstad PR, Malecki M, Flanagan SE, Larkin B, et al. Swiching from insulin to oral sulphonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine. 2006;355(5):467–477
21. Goto Y, Nonaka I, Horai S. A mutation in the tRNA Leu (UUR) gene associated with the MELAS subgroup of mitochondrial DNA (Maternally inherited diabetes and deafness or MIDD). Diabetes Metabolism. 1990;30:181–186
22. Pearson ER, Pruhova S, Tack CJ, et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia. 2005;48:878–885
    • MEDLINE
23. Shepherd M. Transforming lives: transferring patients with neonatal diabetes from insulin to sulphonylureas. European Diabetes Nursing. 2006;3(3):137–142
24. M. Rafiq, S.E. Flanagan, A.M. Patch, B.M. Shields, Neonatal Diabetes International Collaborative group, in: S. Ellard, A.T. Hattersley (Eds.), Effective treatment with oral sulphonylureas in patients with diabetes due to SUR1 mutations, Diabetes Care 31 (2008) 204–209.
25. Shepherd M, Hattersley AT, Ellard S. Integration of the MODY link nurse project: 20 month evaluation. Journal of Diabetes Nursing. 2005;9, 2:47–52